ABCG2 and Alzheimer disease: Moreover, studies have found that the brain distribution of dual ABCB1/ABCG2 substrates is unchanged in an AD mouse model (APPPS1-21), indicating that the brain distribution of clinically used ABCB1/ABCG2 substrate drugs may not differ between AD patients and healthy individuals [226].